Apixaban in Japanese patients with cancer-associated venous thromboembolism: a multi-center phase II trial-Reference-Cited by-同舟云学术

Apixaban in Japanese patients with cancer-associated venous thromboembolism: a multi-center phase II trial

Published:2022-01-25 Issue:4 Volume:115 Page:499-507
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Imamura Yoshinori^ORCID,Otsui Kazunori,Mori Kenta,Kitagawa Koichi,Okada Hideaki,Hata Akito,Hayashi Hidetoshi,Nose Taku,Ohata Shinya,Miyata Yoshiharu,Funakoshi Yohei,Toyoda Masanori,Yakushijin Kimikazu,Kiyota Naomi,Matsuoka Hiroshi,Minami Hironobu

Funder

Training Plan for Oncology Professionals, Japan

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

https://link.springer.com/content/pdf/10.1007/s12185-022-03289-w.pdf

Reference47 articles.

1. Khorana AA. Venous thromboembolism and prognosis in cancer. Thromb Res. 2010;125:490–3. https://doi.org/10.1016/j.thromres.2009.12.023.

2. Prandoni P, Lensing AW, Piccioli A, Bernardi E, Simioni P, Girolami B, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood. 2002;100:3484–8. https://doi.org/10.1182/blood-2002-01-0108.

3. Farge D, Frere C, Connors JM, Ay C, Khorana AA, Munoz A, et al. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. Lancet Oncol. 2019;20:e566–81. https://doi.org/10.1016/S1470-2045(19)30336-5.

4. Key NS, Khorana AA, Kuderer NM, Bohike K, Lee AY, Arcelus JI, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2020;38:496–520. https://doi.org/10.1200/JCO.19.01461.

5. Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenz D, Bounameaux H, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149:315–52. https://doi.org/10.1016/j.chest.2015.11.026.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Status of Venous Thromboembolism in Japanese;The Japanese Journal of Phlebology;2024-04-27

2. 1) Cancer Therapy-related Cardiac Dysfunction;Nihon Naika Gakkai Zasshi;2023-09-10

3. Risk of intracranial hemorrhage with direct oral anticoagulation versus low molecular weight heparin in the treatment of brain tumor-associated venous thromboembolism: A meta-analysis;Journal of Stroke and Cerebrovascular Diseases;2023-08

4. Efficacy and safety of direct oral anticoagulants for the treatment of cancer-associated venous thromboembolism: A systematic review and Bayesian network meta-analysis;Medicina Clínica;2023-03

5. Efficacy and safety of direct oral anticoagulants for the treatment of cancer-associated venous thromboembolism: A systematic review and Bayesian network meta-analysis;Medicina Clínica (English Edition);2023-03